physIQ

Cancer-focused CRO OncoBay signs on with physIQ’s latest clinical trial partner program

November 17, 2022

Originally published in Fierce Biotech

Life Sciences Media Mentions
Read More

Innovative Oncology CRO OncoBay Clinical Joins physIQ Intrepid Partner Program

November 15, 2022

 

Life Sciences Press Releases
Read More

physIQ unveils new partner program for CROs, other research groups

November 11, 2022

Originally published in FierceBiotech

Life Sciences Media Mentions
Read More

physIQ Launches the Intrepid Partner Program

November 9, 2022

   

Corporate Life Sciences Press Releases
Read More

Oncology Clinician-Scientist Jason Luke, MD Named physIQ Medical Advisor

October 18, 2022

 

Corporate Press Releases
Read More

Legacy Leaders: Dr. Steven Steinhubl

September 6, 2022

Originally published in PharmaVoice 100

Life Sciences Media Mentions
Read More

InCarda, PhysIQ and Syneos team for phase 3 flecainide study

August 31, 2022

Originally published in Fierce Biotech

Life Sciences Media Mentions
Read More

Syneos joins with physIQ, InCarda on atrial fibrillation study

August 30, 2022

Originally published in Outsourcing Pharma

Life Sciences Media Mentions
Read More

People on the Move: Michael Neeb

August 29, 2022

Originally published in Crain's Chicago Business

Corporate Media Mentions
Read More

physIQ Announces Collaboration with InCarda Therapeutics and Syneos Health

August 24, 2022

Originally published in Applied Clinical Trials

Life Sciences Media Mentions
Read More
1 2 3 4 5 Next